Pharmacodynamics of Antimicrobial Therapy

[1]  R. Hatala,et al.  Once-Daily Aminoglycoside Dosing in Immunocompetent Adults , 1996, Annals of Internal Medicine.

[2]  J. Mouton,et al.  Killing of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model , 1994, Antimicrobial Agents and Chemotherapy.

[3]  J J Schentag,et al.  Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients , 1993, Antimicrobial Agents and Chemotherapy.

[4]  W. Craig,et al.  Continuous infusion of beta-lactam antibiotics , 1992, Antimicrobial Agents and Chemotherapy.

[5]  J. Steckelberg,et al.  Cephalosporin antimicrobial agents and related compounds. , 1991, Mayo Clinic proceedings.

[6]  L. Nilsson,et al.  Pharmacodynamics of daptomycin and vancomycin on Enterococcus faecalis and Staphylococcus aureus demonstrated by studies of initial killing and postantibiotic effect and influence of Ca2+ and albumin on these drugs , 1991, Antimicrobial Agents and Chemotherapy.

[7]  I. Trujillano,et al.  Meropenem: in-vitro activity and kinetics of activity against organisms of the Bacteroides fragilis group. , 1991, The Journal of antimicrobial chemotherapy.

[8]  D. Gilbert.  Once-daily aminoglycoside therapy , 1991, Antimicrobial Agents and Chemotherapy.

[9]  E. Prens,et al.  Pharmacokinetics of ceftazidime in serum and suction blister fluid during continuous and intermittent infusions in healthy volunteers , 1990, Antimicrobial Agents and Chemotherapy.

[10]  J. Solomkin,et al.  Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections. , 1990, Annals of surgery.

[11]  R. Brummett,et al.  Vancomycin- and erythromycin-induced hearing loss in humans , 1989, Antimicrobial Agents and Chemotherapy.

[12]  M. Levison,et al.  Postantibiotic effect of penicillin plus gentamicin versus Enterococcus faecalis in vitro and in vivo , 1989, Antimicrobial Agents and Chemotherapy.

[13]  G. Drusano.  Role of pharmacokinetics in the outcome of infections , 1988, Antimicrobial Agents and Chemotherapy.

[14]  Neu Hc,et al.  Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria. , 1987 .

[15]  E. Culebras,et al.  Postantibiotic effect of imipenem on gram-positive and gram-negative micro-organisms. , 1986, The Journal of antimicrobial chemotherapy.

[16]  R. Moore,et al.  Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia. , 1984, The American journal of medicine.

[17]  B. Farber,et al.  Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981 , 1983, Antimicrobial Agents and Chemotherapy.

[18]  T. Sorrell,et al.  Vancomycin therapy for methicillin-resistant Staphylococcus aureus. , 1982, Annals of internal medicine.

[19]  P. Traber,et al.  Vancomycin Ototoxicity in patient with normal renal function. , 1981, Annals of Internal Medicine.

[20]  G. Bodey,et al.  A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients. , 1979, The American journal of medicine.

[21]  E. Berman,et al.  A review of results of clinical trials with amikacin. , 1976, The Journal of infectious diseases.

[22]  W. Hewitt,et al.  Gentamicin Blood Levels: a Guide to Nephrotoxicity , 1975, Antimicrobial Agents and Chemotherapy.

[23]  J R Pattison,et al.  Experience in Monitoring Gentamicin Therapy during Treatment of Serious Gram-Negative Sepsis , 1974, British medical journal.

[24]  S. B. Lucas,et al.  Prescribing aids for gentamicin. , 1974, British journal of clinical pharmacology.

[25]  H. Neu,et al.  Quinolone antimicrobial agents. , 1992, Annual review of medicine.

[26]  R. Moore,et al.  Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration. , 1987, The Journal of infectious diseases.

[27]  D. Zaske,et al.  Increased burn patient survival with individualized dosages of gentamicin. , 1982, Surgery.

[28]  G. Mccracken,et al.  Clinical pharmacology and efficacy of vancomycin in pediatric patients. , 1980, The Journal of pediatrics.